follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Advaxis closes $26.5M public offering

Back to Top Comments Email Print

News You Can Use

Latest News

    advertisement

    Advaxis Inc., a Princeton biotech specializing in drugs treating cancer and infectious diseases, announced Tuesday the closing of its recent public offering.

    Continue Reading »»

    Share This Story On:
    advertisement

    Comments


    Be the first to comment.



    Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

    Post Comment
         View Comment Policy

    Advanced search
    Sponsored by
    advertisement
      
      
    advertisement
      
      
    advertisement
    Back to Top